{
    "clinical_study": {
        "@rank": "60526", 
        "acronym": "CUPACS", 
        "arm_group": [
            {
                "arm_group_label": "cranberry extract 1", 
                "arm_group_type": "Experimental", 
                "description": "One capsule with a proanthocyanidin standardized cranberry extract of 36 mg and one capsule of placebo cranberry extract."
            }, 
            {
                "arm_group_label": "cranberry extract 2.", 
                "arm_group_type": "Experimental", 
                "description": "Two capsules with a proanthocyanidin standardized cranberry extract of 36 mg."
            }, 
            {
                "arm_group_label": "cranberry extract 3.", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Two capsules with a proanthocyanidin standardized cranberry extract of 2 mg."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this cross over pilot study is to investigate the urinary catabolites of\n      Proanthocyanidines (PACs) as biomarkers of cranberry extracts in healthy young women."
        }, 
        "brief_title": "Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Urinary Tract Infections", 
        "condition_browse": {
            "mesh_term": "Urinary Tract Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy women.\n\n          -  18 to 40 years.\n\n        Exclusion Criteria:\n\n          -  No internet access.\n\n          -  No refrigerator access during the 9 hours of sample collection.\n\n          -  Women who had or expect to take antibiotic.\n\n          -  Women who had or expect to take cranberries, blueberries or bilberries in the form of\n             berries, juice or extracts.\n\n          -  Women who had or expect to take dark chocolate.\n\n          -  Women who had personal history of acute or chronic renal failure."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02087735", 
            "org_study_id": "PACS-2013-SD"
        }, 
        "intervention": {
            "arm_group_label": [
                "cranberry extract 1", 
                "cranberry extract 2."
            ], 
            "description": "The aim of this pilot study is to evaluate the urinary catabolites of PACs as a biomarker of consumption of cranberry extracts within 9 hours of intercourse. Once a week, for 3 weeks, the women will receive a sequence of 3 different cranberry extracts (72 mg, 36 mg and 2mg (placebo)). The participant will have to collect its urine for a period of 9 hours in 3 different containers (one different container for 3 hours).", 
            "intervention_name": "Cranberry extract", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Proanthocyanidin", 
                "Procyanidin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cranberry", 
            "Proanthocyanidins", 
            "Urinary catabolites"
        ], 
        "lastchanged_date": "March 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Qu\u00e9bec", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "G1V 0A6"
                }, 
                "name": "Laval University, Department of Medecine, Institut sur la nutrition et les aliments fonctionnels (INAF)."
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "Measurement of Urinary Catabolites of the Proanthocyanidines (PACs) in Healthy Young Women as Biomarkers of Consumption of Cranberry Extracts.", 
        "overall_official": {
            "affiliation": "Laval University", 
            "last_name": "Sylvie Dodin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Canadian Institutes of Health Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Urinary catabolites of PACs", 
            "safety_issue": "No", 
            "time_frame": "within 9 hours following the intake of cranberry extracts"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02087735"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Laval University", 
            "investigator_full_name": "Sylvie Dodin", 
            "investigator_title": "Sylvie Dodin, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Laval University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Laval University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}